CDSCO
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment
Union Budget 2026 boosts India’s biopharma ambitions: USAIC
NDCT amendments to reduce drug development timelines, boost pharma innovation
CDSCO labs flag 211 drug samples as ‘not of standard quality’ in October
Centre sets Jan 1 deadline for states to ensure pharma firms meet global norms
PIL in SC over deaths of children linked to contaminated cough syrup
CDSCO flags 94 drug samples as ‘not of standard quality’ in August
AiMeD welcomes govt’s GST rate cut, MRP implementation relief for medical devices
Health Ministry to amend rules for new drug, clinical trials to promote ease of doing business
Paracetamol drug not banned in India, says Anupriya Patel
CDSCO Publishes List of NSQ and Spurious Drugs for November 2024
India Needs To Have World Class Regulatory Framework To Match 'Pharmacy Of The World' Reputation: Nadda
Following an inspection, Marion Biotech ceased all production
World's First Intra-Nasal Vaccine For COVID Gets CDSCO Nod For Restricted Use In Emergency Situations